1,3-dipropyl-8-cyclopentylxanthine has been researched along with angiotensin iii in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Briggs, JP; He, XR; Lorenz, JN; Schnermann, J; Skøtt, O; Weihprecht, H | 1 |
Georgiev, V; Kambourova, T; Tchekalarova, J | 1 |
2 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and angiotensin iii
Article | Year |
---|---|
Effects of adenosine and angiotensin on macula densa-stimulated renin secretion.
Topics: Adenosine; Angiotensin II; Angiotensin III; Animals; Female; Juxtaglomerular Apparatus; Pentostatin; Rabbits; Renin; Xanthines | 1993 |
Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): interaction with adenosine A(1) receptors.
Topics: Adenosine; Angiotensin II; Angiotensin III; Angiotensins; Animals; Brain; Convulsants; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy; Kindling, Neurologic; Male; Mice; Mice, Inbred ICR; Pentylenetetrazole; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Seizures; Xanthines | 2001 |